Before the Wall Street opening bell on Tuesday, Boston Scientific Corp. reported plans to acquire privately held Relievant Medsystems Inc. for $850 million in cash at closing plus undisclosed payments contingent on sales performance of the company’s lead product, the Intracept intraosseous nerve ablation system, over the next three years.
University Orthopedics in East Providence, Rhode Island is the first in the state to offer the Intracept spine procedure, a minimally invasive, implant-free pro